Colorectal Neoplasms, Hereditary Nonpolyposis
7
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Smart Measurement of Circulating Tumor DNA
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer
Risk-Reducing Surgeries for Hereditary Ovarian Cancer
CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome
Implementation of Guidelines on Hereditary or Familial Colorectal Cancer
Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer Surveillance